Radient Pharmaceuticals Corporation fka RXPC

[guardiangel]

Jimtash do you want us to "tell" Reese to "Add" update his latest NEWS on the Provista/Radient web site as well? ahooooololooooooooooooooo

http://www.biospace.com/News/provista-diagnostics-nabs-3-9-million-in-hopes-of/368958

http://www.biospace.com/News/provista-diagnostics-to-present-at-leerink-global/363952

http://www.provistadx.com/home/news-and-events




livinginsv Thursday, 03/26/15 11:12:32 AM
Re: guardiangel post# 28514
Post # of 28518

tell reese you ADDED to HIS pipeline . . .


Latest
March 9, 2015
Provista Diagnostics presented data from key clinical studies utilizing a proprietary novel blood-based combinatorial biomarker assay at The 2015 Miami Breast Cancer Conference®, held February 26 – March 1, 2015 in Miami, Florida.
December 10, 2014
Provista Diagnostics to Present Data from a Prospective Clinical Trial at the 2014 San Antonio Breast Cancer Symposium. Data Highlights the Role of Serum Protein Biomarkers in Conjunction with Tumor Associated Autoantibodies to Distinguish Benign from Invasive Breast Lesions
December 5, 2014
Provista Diagnostics’ Blood-based Diagnostic Featured in Oncology & Hematology Review. Highlights the Potential of Serum Protein Biomarkers in Conjunction with Tumor Associated Autoantibodies to Improve Early Detection of Breast Cancer in conjunction with standard imaging practices
November 10, 2014
Provista Diagnostics Accepted for a Late-Breaking Data Presentation at the 2014 San Antonio Breast Cancer Symposium: Data Explores the Ability of Serum Protein Biomarkers in Conjunction with Tumor Associated Autoantibodies to Distinguish Between Benign and Invasive Breast Lesions
September 26, 2014
Provista Diagnostics to Participate in BTIG’s Inaugural Emergin Technologies in Healthcare Diagnostics Symposium
September 9, 2014
ASCO: Provista's autoantibody/biomarker combo boosts breast cancer screening accuracy
September 9, 2014
Provista Diagnostics, Inc. to Present at Rodman & Renshaw Annual Global Investment Conference
September 8, 2014
Provista Diagnostics Announces Key Data Presented at the American Society of Clinical Oncologist Breast 2014 Annual Meeting: Data Demonstrates the Ability of Serum Protein Biomarkers in Conjunction with Autoantibodies to Distinguish Between Invasive Breast Cancer and Benign Breast Conditions
August 18, 2014
Provista Diagnostics, Inc. Joins Personalized Medicine Coalition (PMC)
July 15, 2014
Provista Diagnostics Completes Enrollment of its 001 Prospective Study of Protein-Based Biomarker Blood Test to Aid in Detection of Breast Cancer Prospective, Randomized, Multi-Center Study For Breast Cancer Detection in 351 Female Patients with Suspicious Breast Lesions
July 7, 2014
Provista Diagnostics, Inc. Appoints Rao V. Mulpuri, PhD, MBA, as Chief Operating Officer
June 26, 2014
Provista Diagnostics Laboratory Receives Accreditation from College of American Pathologists (CAP)
June 7, 2014
Provista Diagnostics, Inc. Joins AdvaMed Dx
May 27, 2014
Provista Diagnostics Expands Exclusive License Agreement for Biomarker Technologies Developed at the Biodesign Institute at Arizona State University
May 19, 2014
Provista Diagnostics Announces First Patient Enrolled in Prospective, Proof-of-Concept Study of its Protein Biomarker Blood Test to Assess Presence of Breast Cancer
April 25, 2014
Provista Diagnostics Secures $6MM Series B Financing
March 3, 2014
Initiated new 500 patient Clinical Trial - 002 in breast cancer for women ages 25-75